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OBJECTIVE—To examine trends in nontraumatic lower-extremity amputations (LEAs) over
an 8-year period in patients with and without diabetes in Spain.
RESEARCH DESIGN AND METHODS—We identiﬁed all patients who underwent an
LEA using national hospital discharge data. Discharges were grouped by diabetes status: type 1
diabetes, type 2diabetes,and no diabetes. The incidence of dischargesattributedto amputations
werecalculatedoverallandstratiﬁedbydiabetesstatusandyear.Wecalculatedlengthofstayand
in-hospital fatality stratiﬁed by diabetes status and type of LEA.
RESULTS—From2001 to 2008, 46,536minorLEAsand43,528 majorLEAswereperformed.
In patients with type 1 diabetes, the incidence of minor and major amputations decreased
signiﬁcantly from 2001 to 2008 (0.88–0.43 per 100,000 inhabitants and 0.59–0.22 per
100,000 inhabitants, respectively). In patients with type 2 diabetes, the incidence of minor
and major LEAs increased signiﬁcantly (9.23–10.9 per 100,000 inhabitants and 7.12–7.47 per
100,000 inhabitants). Hospital stay was similar among type 1 diabetic and type 2 diabetic sub-
jects, according to the type of LEA. Only in-hospital mortality for minor LEAs among type 1
diabetic subjects decreased signiﬁcantly (4.0% in 2001 vs. 1.6% in 2008).
CONCLUSIONS—Our national data show a decrease in the incidence of major and minor
LEAs in patients with type 1 diabetes and an increase among patients with type 2 diabetes.
Further improvement is necessary in the preventive care and early treatment of patients with
diabetes. The management of foot lesions, especially among type 2 diabetic patients, is partic-
ularly urgent.
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T
he prevalence of lower-extremity
disease, including peripheral arterial
disease and peripheral neuropathy,
is twice as high in individuals with di-
abetes as in the general population (1,2).
Despite intensive interventions, many of
these patients require a lower-extremity
amputation (LEA), which has a high so-
cial impact and poor clinical prognosis as
well as considerable ﬁnancial implica-
tions for health care systems (1). LEA
rates are 15–40 times higher in diabetic
patients than in nondiabetic patients (3).
The prevalence of diabetes in the
Spanish population is ~5–6%, and this
ﬁgure increases with age (4). This is
expected to lead to an increase in the
number of amputations (1). However,
Krishnan et al. (5) suggested that appro-
priate multidisciplinary care of patients
with diabetes can actually reduce the in-
cidence of LEAs by up to 70%.
Vamos et al. (2) indicated that trends
in amputation procedures can help im-
prove our understanding of the burden
of diabetes and could be used to inform
future health care planning. In Spain, lit-
tle information is available on the trends
and associated outcomes of LEAs (6,7).
We used national hospital discharge
data to examine trends in the incidence
of LEA procedures (major and minor) in
patients with type 1 and type 2 diabetes
between2001and2008inSpain.Wealso
analyzed outcomes of discharge, such
as length of stay (LOS) and in-hospital
mortality.
RESEARCH DESIGN AND
METHODS—The Spanish Minimum
Basic Data Set (MBDS) was used as the
data source. This national hospital data-
base is managed by the Spanish Ministry
of Health (8) and includes hospital de-
tails, patient data, surgical and obstetric
procedures, other procedures, and date
and type of discharge. The Spanish Min-
istry of Health sets standards for registra-
tion and performs periodic audits (8).
Diagnoses and surgical procedures
were assigned using the ICD-9-CM; all
inpatients in the MBDS database had a
primary surgical procedure and/or pri-
mary diagnosis and up to 20 procedures
and/or 14 diagnoses coded at discharge.
Amputations were identiﬁed as any
procedure code for LEA in any procedure
ﬁeld between 1 January 2001 and 31
December 2008. A minor amputation
was deﬁned as any LEA distal to the ankle
joint (ICD-9-CM codes 84.10–84.12); a
major amputation was deﬁned as any
LEAthroughorproximaltotheanklejoint
(ICD-9-CM codes 84.13–84.17). All trau-
maticLEAs,deﬁnedbyanytrauma-related
codeofthe lowerextremity inanydiagno-
sis ﬁeld, were excluded (ICD-9-CM codes
895–897, 905.9, 928–929, and 959). Dis-
chargesweregroupedbydiabetesstatusas
follows:nodiabetes,type1diabetes(ICD-
9-CMcodes250.x1and250.x3),andtype
2 diabetes (ICD-9-CM codes: 250.x0 and
250.x2). No unique identiﬁers were avail-
able when patient data were obtained;
therefore, it was not possible to identify
multiple amputations in an individual un-
less the subsequent amputation occurred
duringthesamehospitalstay.Forpatients
with multiple LEAs during their stay, only
the highest LEA was used in the data anal-
ysis. We calculated LOS and in-hospital
fatality stratiﬁed by diabetes status and
type of LEA.
The incidence of discharges after am-
putation was calculated overall and by
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ORIGINAL ARTICLEdiabetes status for each year. We calcu-
lated the yearly age- and sex-speciﬁci n -
cidence rates (per 100,000 inhabitants)
by dividing the number of cases per year
per sex and age-groupby thecorrespond-
ing number of people in that population
group, according to the National Insti-
tute of Statistics on 31 December of each
year (9).
Statistical analyses were performed
using Stata version 10.1 (Stata, College
Station, TX).Adescriptive statisticalanal-
ysis was performed for all the continuous
variables and categories by stratifying
LEAs as major or minor. To test the time
trend in the incidence of LEA procedures,
we ﬁtted separate Poisson regression
models for patients with and without
diabetes, using year of discharge, sex,
and age as independent variables. For
in-hospital mortality, logistic regression
analyses were performed with mortality
as a binary outcome using the same
variables. In these models, an interaction
term for diabetes and year of discharge
was tested and included if P , 0.05.
Data conﬁdentiality was maintained
at all times according to Spanish legisla-
tion. Patient identiﬁers were deleted be-
fore the database was provided to the
authors in order to maintain patient
anonymity. It is not possible to identify
patients at individual levels, either in this
article or in the database. Given the
anonymous and mandatory nature of
the dataset, the requirement for informed
consent was not necessary.
RESULTS—Between 2001 and 2008,
90,064nontraumaticamputations(46,536
minor and 43,528 major) corresponding
to 86,023 discharges were performed in
Spain. Simultaneous bilateral procedures
were recorded in 4.4% (n = 4,041) of
cases. Over the study period, 64.5% of
all discharges after a nontraumatic LEA
occurred in patients with diabetes, with
type 1 diabetic patients accounting for
3.5% and type 2 diabetic patients for
61.0% of discharges.
The mean age of patients who un-
derwent LEAs was (means 6 SD) 69.5 6
14.6 years: patients with type 1 diabetes
were aged 62.09 6 14.9 years; patients
with type 2 diabetes were aged 70.7 6
11.0 years; and patients without diabetes
were aged 70.2 6 11.4 years. A consider-
able male predominance was observed in
LEAs among patients with diabetes, with
themale-to-femaleratiobeing .2:1(type
1 diabetes: 2.23, type 2 diabetes: 2.18,
and no diabetes: 2.4). Minor LEAs were
more common than major LEAs in pa-
tientswith diabetes (minor-to-majorratio
1.69 [95% CI 1.61–1.78] for type 1 dia-
betes and 1.39 [1.37–1.40] for type 2 di-
abetes).
Minor LEAs
Between 2001 and 2008, the overall
number of nontraumatic minor LEAs in
Spain increased from 5,327 to 6,378. The
incidence of minor amputations in pa-
tients with type 1 diabetes decreased
signiﬁcantly from 0.88 (95% CI 0.79–
0.98) to 0.43 (0.37–0.50) per 100,000
inhabitants. In patients with type 2 di-
abetes, the incidence of minor LEAs
increased signiﬁcantly from 9.23 (8.92–
9.55) to 10.97 (10.66–11.29) per 100,000
inhabitants during the study period
(Fig. 1).
The mean age of patients undergoing
a minor amputation was 66.9 6 14.6
years. No signiﬁcant change in age was
observed during the study period. How-
ever, patients with type 2 diabetes were
signiﬁcantly older than those with type 1
diabetes (aged 68.6 vs. 59.8 years; P ,
0.05) (Table 1).
LOS was similar among patients un-
dergoing minor LEAs. Multivariate anal-
ysis revealed that LOS did not change in
patients with type 1 diabetes, type 2 di-
abetes, or those without diabetes during
the study period (Table 2). In-hospital
mortality rates for type 1 diabetes–related
minor LEAs decreased signiﬁcantly dur-
ing the study period (4.0% in 2001 vs.
1.6% in 2008) after adjustment for age,
s e x ,a n dy e a r .W ef o u n dn os i g n i ﬁcant
change over time for in-hospital mortal-
ity rate, type 2 diabetes, or no diabetes
(Table 2).
Major LEAs
The number of major nontraumatic am-
putations increased from 5,211 to 5,474
during the study period. The incidence of
major amputations decreased signiﬁ-
cantly from 0.59 (95% CI 0.51–0.67) to
0.22(0.17–0.26)per100,000inhabitants
inpatientswithtype1diabetes.However,
in patients with type 2 diabetes, the inci-
dence of major LEAs increased signiﬁ-
cantly from 7.12 (6.84–7.40) to 7.47
(7.21–7.73) (Fig. 1).
The mean age of patients undergoing
a major amputation was 72 6 14 years.
Therewasnosigniﬁcantchangeinagedur-
ing the study period. However, patients
with type 2 diabetes were signiﬁcantly
older than those with type 1 diabetes
(73.6 vs. 65.8 years; P , 0.05) (Table 1).
LOS was similar among patients un-
dergoing major LEAs. Multivariate anal-
y s i sd i dn o tr e v e a lc h a n g e si nL O Si n
patients with type 1 diabetes, type 2 di-
abetes, or those without diabetes during
the study period (Table 3). In-hospital
mortality rates for type 1 diabetes–related
majorLEAsdidnotchange(8.3%in2001
vs. 8.7% in 2008); however, they in-
creased for type 2 diabetes (9.7% in
2001 vs. 10.1% in 2008) and decreased
for major LEAs in patients without diabe-
tes (15.1% in 2001 vs. 14.0% in 2008).
Logistic regression analysis showed no
signiﬁcant change in hospital mortality
rates associated with major LEAs after ad-
justment for age, sex, and year (Table 3).
CONCLUSIONS—Toourknowledge,
this is the ﬁrst nationwide analysis of the
incidence of diabetes-related minor and
major LEAs in Spain. Our results reveal a
reduction in the overall number of non-
traumatic LEAs between 2001 and 2008,
with different trends in minor and major
LEAs in patients with type 1 diabetes and
patients without diabetes. An upward
trend was observed in type 2 diabetes–
related minor and major LEAs; however,
the absolute increase was small.
Previous studies reporting a decrease
in the incidence of LEAs in patients with
diabetes stated that they were performed
by researchers who were highly special-
ized in diabetic foot care and working
in centers with well-established vascular
services (5,10). In northern Europe, an
increase in the proportion of hospitals
with specialist diabetic podiatry services
(32–72%) was associated with a drop in
the rate of diabetes-related major ampu-
tations, from 5.5 to 3.6 per 100,000 peo-
ple, despite a rise in the prevalence of
diabetes (11,12).
In Spain, studies (6,7) from several
geographical areas showed decreasing
LEA rates in patients with diabetes. Other
Spanish regional studies (13,14) indi-
cated that LEA rates in populations
with or without diabetes are higher than
previously reported; however, national
population-based data on trends in LEAs
in Spain are lacking.
In 2007, Trautner et al. (15) found a
signiﬁcant reduction in the incidence of
LEAs between 1990 and 2005 in diabetic
patients, although this remained un-
changed in nondiabetic patients. The re-
duction in relative risk was particularly
clear for major amputations. The authors
explained their ﬁndings by referring to
the implementation of intensive diabetic
care.diabetesjournals.org DIABETES CARE, VOLUME 34, JULY 2011 1571
López-de-Andrés and AssociatesFigure 1—Changes in minor and major LEA incidence rates in patients with type 1 diabetes expressed per 100,000 inhabitants (A) and inpatients
with type 2 diabetes expressed per 100,000 inhabitants (B) (Spain, 2001–2008). *P , 0.05 (Poisson regression analysis). Population data were
obtained from the Spanish National Institute of Statistics (9). The estimated total population was 40,964,000 in 2001; 41,663,000 in 2002;
42,345,000 in 2003; 43,038,000 in 2004; 43,758,000 in 2005; 44,474,000 in 2006; 45,283,000 in 2007; and 45,828,000 in 2008.
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Trends in lower-extremity amputations in Spainfoot care in the study region. This is con-
sistent with our results and with those of
studies from other countries where a re-
ductioninthenumberofLEAsperformed
on diabetic subjects was observed (16).
The upward trend in LEAs in patients
with type 2 diabetes likely reﬂects a num-
ber of factors, such as improved survival
of patients, increases in prevalence and
incidence, greater awareness of diabetic
foot disease, improved specialist services
and agreement between the patient and
the expert that loss of the limb is (or is
not) the best option (2,4,17). Available
information shows that the prevalence
of type 2 diabetes is rising in Spain; there-
fore, the increase in LEAs among those
with type 2 diabetes is possibly less pro-
nounced than one would surmise from
our data (4). Separate data for the in-
cidence of LEAs related to type 1 and
type 2 diabetes are rarely documented
in population-based studies (2). Ebskov
et al. (18) indicated that the overall de-
crease in major LEA rates was attrib-
utable to a decline in the number of
patients with type 1 diabetes. In Spain, we
cannot conclude that this decrease in LEA
rates among type 1 diabetic patients is
associated with changes in the prevalence
oftype1diabetes.ZorrillaTorrasetal.(19)
indicated that incidence data showed no
signiﬁcant changes during 1997–2005 for
type 1 diabetes, and other studies (4,19)
in Spain reach similar conclusions. We
agree with Jonasson et al. (20), who sug-
gested that in Sweden the reduction in the
risk of nontraumatic LEAsamong patients
with type 1 diabetes might be attributed
to the introduction of a program for pre-
vention and treatment of ulceration in
patients with diabetes. Furthermore, pre-
vious studies show that patients with type
1 diabetes are more strictly controlled for
risk factors and diabetic foot disease; in
contrast, many patients with type 2 diabe-
tes have less aggressive management of
risk factors (18).
The proportion of minor and major
LEAs was higher in men than in women.
This ﬁnding is consistent with those of
previous studies (2,11). However, the
ﬁnding is not easily explained. Congdon
et al. (21) indicated that although the
prevalence of diagnosed diabetes has in-
creased considerably in men, it may not
fully explain the increasing male predom-
inance in LEAs.
LOS, which may be regarded as a
majordeterminantoftheﬁnancialburden
of diabetes-related LEAs on society, was
found to decrease, although this may
reﬂect general changes in hospital prac-
tices and may not necessarily be a conse-
quenceofeffortstomanagefootdiseasein
patients with diabetes (11). We observed
that the median LEA-related LOS was
similar for minor and major amputations.
One explanation is that in-hospital mor-
tality was ~2.5 times higher for major
LEAs than for minor LEAs, thus account-
ing for the unexpectedly low LOS.
Overall in-hospital mortality rates for
LEAs did not change signiﬁcantly be-
tween 2001 and 2008, except for type 1
diabetes–related minor LEAs. The exact
reason for this trend is not fully under-
stood. Vamos et al. (2) indicated that pa-
tients with type 1 diabetes are more
strictly controlled for risk factors and di-
abetic foot disease. Outcomes such as
LOS may have been inﬂuenced by covar-
iates other than postoperative complica-
tions. In such a scenario, only in-hospital
mortality can be used to draw direct con-
clusions on the complications rate in the
current study.
The strength of our study lies in its
large sample size and standardized meth-
odology. Nevertheless, it does present a
series of limitations. Our data source was
the MBDS, an administrative database
that contains discharge data for Spanish
hospitalizations and uses information the
physician has included in the discharge
report. Therefore, it does not include all
the variables of the clinical history, and
clinical factors might have contributed to
the variability observed in LOS. Physi-
cians usually only record information on
the main diseases (up to 15) and proce-
dures (up to 20). Thus, if the physician
considers that a comorbid condition is
not related, has not increased LOS, or has
complicated the main disease, it will
probably not be reﬂected in the database.
Another limitation of this database is its
anonymity, which makes it impossible to
detect whether the same patient was
admitted more than once during the
same year.
Nevertheless, this dataset, which was
introduced in Spain in 1982, is a man-
datory register, and its coverage is esti-
mated to be .95% (8). Furthermore, it
provides useful information on hospital
management of LEAs, given that it brings
together data from all discharges after
LEAs, regardless of the characteristics of
the attending hospital or the department
Table 1—Hospital discharges after LEAs in Spain, 2001–2008
Minor LEAs Major LEAs Total*
Type 1 diabetes†‡ 59.8 (14.3) 65.8 (15.0) 62.0 (14.9)
Age (years) (%)
,44 332 (16.6) 141 (11.9) 450 (15.0)
45–74 1,296 (64.9) 649 (55.0) 1,836 (61.0)
$75 368 (18.4) 391 (33.1) 724 (24.1)
Sex (%)
Male 1,455 (72.9) 744 (63.0) 2,079 (69.1)
Female 541 (27.1) 437 (37.0) 931 (30.9)
Type 2 diabetes†‡ 68.6 (11.5) 73.6 (10.2) 70.7 (11.0)
Age (years) (%)
,44 699 (2.2) 203 (0.9) 873 (1.7)
45–74 20,822 (64.7) 11,088 (47.8) 30,190 (57.5)
$75 10,664 (33.1) 11,921 (51.4) 21,428 (40.8)
Sex (%)
Male 23,791 (73.9) 14,312 (61.7) 36,027 (68.6)
Female 8,394 (26.1) 8,900 (38.3) 16,464 (31.4)
No diabetes†‡ 63.9 (20.5) 71.1 (17.3) 68.3 (19.0)
Age (years) (%)
,44 2,072 (16.8) 1,727 (9.0) 3,715 (12.2)
45–74 5,682 (46.0) 7,264 (38.0) 12,493 (40.9)
$75 4,601 (37.2) 1,0144 (53.0) 14,314 (46.9)
Sex (%) 9,220 (74.6) 13,355 (69.8) 21,809 (71.5)
Male
Female 3,135 (25.4) 5,780 (30.2) 8,713 (28.5)
Data are means (SD). *Not all the denominators add up to the same number because the same patient can
undergo multiple amputations. †Statistically signiﬁcant differences (P , 0.05) on comparing type 1 diabetes
with type 2 diabetes for minor LEAs. ‡Statistically signiﬁcant differences (P , 0.05) on comparing type 1
diabetes with type 2 diabetes for major LEAs.
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López-de-Andrés and Associatesto which the patient is admitted. Ribera
etal.(22)indicatedthatbecausethequal-
ity of the coding seems to be improving,
administrative databases may become
more useful, not only in estimating raw
rates but in providing characteristics of
hospitalization and adjusted mortality
rates. As a consequence, more patients
with diabetes could be identiﬁed. In
any case, we believe this would only
represent a small effect on amputation
rates (22).
Table 2—Hospital discharges after minor LEAs in Spain, 2001–2008
2001 2002 2003 2004 2005 2006 2007 2008 Total
Type 1 diabetes
Number of discharges* 326 300 313 234 225 222 193 183 1,996
Rate† 0.88 0.8 0.82 0.6 0.57 0.55 0.47 0.43 NA
LOS, median (days) 18 18 19 15 17 18 16 14 17
LOS, interquartile range (days) 3–30 3–29 3–33 3–28 3–32 4–28 3–28 2–27 3–64
N u m b e r o f d e a t h s * 1 3 48776435 2
Percentage of deaths* 4.0 1.3 2.6 3.0 3.1 2.7 2.1 1.6 2.6
Type 2 diabetes
Number of discharges* 3,320 3,615 3,843 4,141 4,118 4,243 4,333 4,572 32,185
Rate† 9.23 9.87 10.29 10.88 10.61 10.72 10.68 10.97 NA
LOS, median (days) 19 19 20 19 18 18 19 18 19
LOS, interquartile range (days) 4–64 4–66 4–66 4–64 4–64 3–60 3–64 3–63 4–64
Number of deaths* 135 148 148 146 156 126 162 161 1,182
Percentage of deaths* 4.1 4.1 3.9 3.5 3.8 3.0 3.7 3.5 3.7
No diabetes
Number of discharges* 1,681 1,567 1,528 1,485 1,444 1,486 1,541 1,623 12,355
Rate† 4.67 4.29 4.09 3.89 3.73 3.76 3.79 3.89 NA
LOS, median (days) 19 19 18 17 18 18 18 17 18
LOS, interquartile range (days) 2–69 2–69 2–74 2–68 2–74 2–77 2–68 2–74 2–71
N u m b e r o f d e a t h s * 7 89 99 89 09 57 18 79 37 1 1
Percentage of deaths* 4.6 6.3 6.4 6.1 6.6 4.8 5.6 5.7 5.8
NA, not available.*Signiﬁcantassociation (P ,0.05) fortime trend among discharges after minor LEAs. †Rate changesin minor LEA incidence rates in patients with
type1diabetes expressedper 100,000inhabitants;in patientswithtype2diabetes expressedper100,000inhabitants; and in patientswithoutdiabetes expressedper
100,000 inhabitants (Spain, 2001–2008).
Table 3—Hospital discharges after major LEAs in Spain, 2001–2008
2001 2002 2003 2004 2005 2006 2007 2008 Total
Type 1 diabetes
Number of discharges* 216 210 183 117 141 119 103 92 1,181
Rate† 0.59 0.57 0.49 0.3 0.36 0.3 0.25 0.22 NA
LOS, median (days) 19 17 17 19 17 16 18 19 18
LOS, interquartile range (days) 5–38 4–72 3–106 5–91 3–69 3–77 4–91 4–89 4–83
Number of deaths 18 17 22 8 12 9 11 8 105
Percentage of deaths 8.3 8.1 12.0 6.8 8.5 7.6 10.7 8.7 8.8
Type 2 diabetes
Number of discharges* 2,484 2,624 2,822 2,970 2,974 3,113 3,112 3,113 23,212
Rate† 7.12 7.33 7.71 7.94 7.77 7.93 7.7 7.47 NA
LOS, median (days) 19 19 19 18 18 18 18 16 18
LOS, interquartile range (days) 5–66 5–69 5–68 5–63 5–69 5–64 5–68 5–66 5–66
Number of deaths 242 269 310 307 313 299 353 313 2,406
Percentage of deaths 9.7 10.3 11.0 10.3 10.5 9.6 11.3 10.1 10.4
No diabetes
Number of discharges 2,511 2,503 2,468 2,390 2,312 2,378 2,304 2,269 19,135
Rate 7.20 7.03 6.75 6.39 6.03 6.06 5.70 5.44 NA
LOS, median (days) 18 17 17 18 18 17 18 19 18
LOS, interquartile range (days) 5–71 5–72 4–72 4–77 4–81 4–80 4–82 4–77 4–77
Number of deaths 380 341 334 330 323 317 294 318 2,637
Percentage of deaths 15.1 13.6 13.5 13.8 14.0 13.3 12.8 14.0 13.8
NA, not available. *Signiﬁcant association (P , 0.05) for time trend among discharges after major LEAs. †Rate changes in major LEA incidence rates in patients with
type1diabetes expressedper 100,000inhabitants;in patientswithtype2diabetes expressedper100,000inhabitants; and in patientswithoutdiabetes expressedper
100,000 inhabitants (Spain, 2001–2008).
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Trends in lower-extremity amputations in SpainThe major limitation of our study is
that we were unable to calculate diabetes
type–speciﬁc incidence rates. In Spain no
nationwide representative studies with
blood glucose measurements or national
diabetes prospective registries are avail-
able, and, consequently, we do not have
denominators to estimate rates for type 1
or 2 diabetes (4). In addition, Jeffcoate
et al. (17) indicated that use of the total
population is necessary when the preva-
lence of diabetes is not well documented.
Because of the impossibility of screening
the whole population for diabetes, con-
cessions had to be made.
Because we cannot distinguish be-
tween the two lower extremities, we have
toassumethatallamputationsduringone
discharge are conducted on the same
limb; therefore, we might underestimate
the number of LEAs. However, we were
able to differentiate between type 1 and
type 2 diabetes and we also included a
nondiabetic comparator. Although con-
cerns about the accuracy of routinely
collected datasets have been raised, these
are periodically audited. As a conse-
quence, the quality and validity of our
dataset has been assessed and proved
useful for health research (22). Despite
these limitations, we believe that the
MBDS is a valid instrument for conduct-
ing epidemiologic studies on chronic dis-
eases. Furthermore, discharge databases
have been widely used by other authors
to assess outcomes, burdens, and trends
in LEA procedures in patients with and
without diabetes (2,16,23,24).
Inconclusion,ournationaldatashow
a decrease in the incidence of major and
minor LEAs in patients with type 1 di-
abetes between 2001 and 2008 in Spain.
The decrease may be related to more
strictly controlled risk factors in these
patients. However, the burden of ampu-
tations increased in patients with type 2
diabetes, suggesting that diabetic foot
care remains suboptimal in Spain. Addi-
tional improvements in preventive care
and early treatment are necessary for
patients with diabetes. The management
offootlesions,especiallyamongpatients
with type 2 diabetes, is particularly
urgent.
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